NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 762 filers reported holding NOVARTIS A G in Q3 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $584,000 | -41.9% | 7,396 | -39.3% | 0.39% | -39.2% |
| Q2 2016 | $1,005,000 | -34.3% | 12,182 | -42.3% | 0.64% | -35.8% |
| Q1 2016 | $1,530,000 | -50.5% | 21,119 | -41.2% | 0.99% | -29.7% |
| Q4 2015 | $3,092,000 | -6.4% | 35,942 | -0.0% | 1.41% | -11.3% |
| Q3 2015 | $3,305,000 | -6.3% | 35,956 | +0.3% | 1.59% | +5.8% |
| Q2 2015 | $3,527,000 | -4.8% | 35,866 | -4.6% | 1.50% | -9.1% |
| Q1 2015 | $3,706,000 | -99.9% | 37,583 | -3.6% | 1.66% | -2.3% |
| Q4 2014 | $3,611,146,000 | +99462.9% | 38,972 | +1.1% | 1.69% | +4.4% |
| Q3 2014 | $3,627,000 | +5.4% | 38,530 | +1.4% | 1.62% | +6.4% |
| Q2 2014 | $3,441,000 | +1.0% | 38,007 | -9.0% | 1.53% | -3.0% |
| Q1 2014 | $3,406,000 | +0.5% | 41,749 | -0.9% | 1.57% | +0.9% |
| Q4 2013 | $3,388,000 | +4.8% | 42,147 | -0.0% | 1.56% | -3.6% |
| Q3 2013 | $3,234,000 | +10.9% | 42,164 | +2.2% | 1.62% | +0.6% |
| Q2 2013 | $2,916,000 | – | 41,239 | – | 1.61% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
| EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
| MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
| Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
| Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
| BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
| Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
| DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
| WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |